Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001437749-25-009203
Filing Date
2025-03-25
Accepted
2025-03-25 17:24:57
Documents
15
Period of Report
2025-03-18
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A wint20250324_8ka.htm   iXBRL 8-K/A 26546
2 EXHIBIT 99.1 ex_793996.htm EX-99.1 13076
  Complete submission text file 0001437749-25-009203.txt   190401

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA wint-20250318.xsd EX-101.SCH 3579
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20250318_def.xml EX-101.DEF 12175
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20250318_lab.xml EX-101.LAB 16369
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20250318_pre.xml EX-101.PRE 12445
17 EXTRACTED XBRL INSTANCE DOCUMENT wint20250324_8ka_htm.xml XML 3101
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

EIN.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39290 | Film No.: 25769409
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)